- Home
- DC vs ANGO Comparison
DC vs ANGO Comparison
Compare DC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DC
- ANGO
- Stock Information
- Founded
- DC 2017
- ANGO 1988
- Country
- DC United States
- ANGO United States
- Employees
- DC N/A
- ANGO N/A
- Industry
- DC Precious Metals
- ANGO Medical/Dental Instruments
- Sector
- DC Basic Materials
- ANGO Health Care
- Exchange
- DC Nasdaq
- ANGO Nasdaq
- Market Cap
- DC 346.9M
- ANGO 406.9M
- IPO Year
- DC N/A
- ANGO 2004
- Fundamental
- Price
- DC $3.76
- ANGO $9.46
- Analyst Decision
- DC Buy
- ANGO Strong Buy
- Analyst Count
- DC 1
- ANGO 2
- Target Price
- DC $7.50
- ANGO $14.00
- AVG Volume (30 Days)
- DC 785.1K
- ANGO 674.5K
- Earning Date
- DC 08-12-2025
- ANGO 07-15-2025
- Dividend Yield
- DC N/A
- ANGO N/A
- EPS Growth
- DC N/A
- ANGO N/A
- EPS
- DC N/A
- ANGO N/A
- Revenue
- DC N/A
- ANGO $283,320,000.00
- Revenue This Year
- DC N/A
- ANGO N/A
- Revenue Next Year
- DC N/A
- ANGO $6.35
- P/E Ratio
- DC N/A
- ANGO N/A
- Revenue Growth
- DC N/A
- ANGO N/A
- 52 Week Low
- DC $1.84
- ANGO $5.47
- 52 Week High
- DC $4.11
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- DC 57.22
- ANGO 38.52
- Support Level
- DC $3.62
- ANGO $9.68
- Resistance Level
- DC $3.85
- ANGO $10.24
- Average True Range (ATR)
- DC 0.12
- ANGO 0.40
- MACD
- DC -0.05
- ANGO -0.15
- Stochastic Oscillator
- DC 28.57
- ANGO -0.01
About DC Dakota Gold Corp.
Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 48 thousand acres surrounding the historic Homestake Mine. Company project includes Richmond Hill Project.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.